Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ángel Estébanez"'
Autor:
Irene Carretero-Barrio, Lara Pijuan, Adrián Illarramendi, Daniel Curto, Fernando López-Ríos, Ángel Estébanez-Gallo, Josep Castellvi, Sofía Granados-Aparici, Desamparados Compañ-Quilis, Rosa Noguera, Isabel Esteban-Rodríguez, Ignacio Sánchez-Güerri, Ana Delia Ramos-Guerra, Juan Enrique Ortuño, Pilar Garrido, María Jesús Ledesma-Carbayo, Amparo Benito, José Palacios
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The incorporation of digital pathology in clinical practice will require the training of pathologists in digital skills. Our study aimed to assess the reliability among pathologists in determining tumor percentage in whole slide images (WSI)
Externí odkaz:
https://doaj.org/article/a9844491cfaf44f3a06678590667aee4
Autor:
José Manuel Sousa, Mercedes Vergara, Federico Pulido, Gloria Sánchez Antolín, Lander Hijona, Fernando Carnicer, Diego Rincón, Javier Salmerón, Beatriz Mateos-Muñoz, Antoni Jou, Benjamín Polo-Lorduy, Ángel Rubín, Ana Escarda, Patricia Aguilar, Teresa Aldámiz-Echevarría, Luisa García-Buey, José A Carrión, Manuel Hernández-Guerra, Sonia Chimeno-Hernández, Nuria Espinosa, Rosa Mª Morillas, Raúl J Andrade, Manuel Delgado, Adolfo Gallego, Marta Magaz, José María Moreno-Planas, Ángel Estébanez, Mikel Rico, Fernando Menéndez, Blanca Sampedro, Luís Morano, Sonia Izquierdo, José Manuel Zozaya, Manuel Rodríguez, Senador Morán-Sánchez, Sara Lorente, Ignacio Martín-Granizo, Miguel Ángel Von-Wichmann, Marcial Delgado, Amanda Manzanares
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225061 (2019)
AimWe describe the effectiveness and safety of the interferon-free regimen ombitasvir/paritaprevir/ritonavir plus dasabuvir with or without ribavirin (OBV/PTV/r ± DSV ± RBV) in a nationwide representative sample of the hepatitis C virus (HCV) monoi
Externí odkaz:
https://doaj.org/article/7dbb76fef2474e14bc130178fddbd4a1
Autor:
María Teresa Arias-Loste, Paula Iruzubieta, Ángela Puente, David Ramos, Carolina Santa Cruz, Ángel Estébanez, Susana Llerena, Carmen Alonso-Martín, David San Segundo, Lorena Álvarez, Antonio López Useros, Emilio Fábrega, Marcos López-Hoyos, Javier Crespo
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 11, p 1878 (2016)
Current evidence suggests that gut dysbiosis drives obesity and non-alcoholic fatty liver disease (NAFLD) pathogenesis. Toll-like receptor 2 (TLR2) and TLR6 specifically recognize components of Gram-positive bacteria. Despite the potential implicatio
Externí odkaz:
https://doaj.org/article/6c109ec671384916a5f9fe90a8160a85
Autor:
Ángela Puente, Joaquín Cabezas, María Jesús López Arias, José Ignacio Fortea, María Teresa Arias, Ángel Estébanez, Fernando Casafont, Emilio Fábrega, Javier Crespo
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 1, Pp 17-25
Background and aims: The regression of liver fibrosis and portal hypertension (PH) and their influence on the natural history of compensated hepatitis C virus (HCV)-related cirrhosis has not been studied previously. Our objective was to evaluate the
Externí odkaz:
https://doaj.org/article/c509f5b9a794423bb1d2f332676708f1